| [1] | Chen WANG, Min WANG, Ke ZHANG, Jinxing ZHANG, Li LIU, Zhining FAN. Imaging features and therapeutic strategies for lethal iatrogenic hemobilia[J]. Journal of Clinical Hepatology, 2024, 40(10): 2070-2074. doi: 10.12449/JCH241022 |
| [2] | Yao Xin, Zhou Hao, Tang ShanHong, Huang Shan, Chen XueLing, Qin JianPing. Effect of intraoperative Viatorr stent implantation for shunting of blood flow in the left or right branch of the portal vein and its effect on clinical outcome in patients with cirrhotic portal hypertension undergoing transjugular intrahepatic portosystemic shunt[J]. Journal of Clinical Hepatology, 2020, 36(9): 1970-1974. doi: 10.3969/j.issn.1001-5256.2020.09.012 |
| [3] | Zhou YangChun, Chu ChaoShun. Preduodenal portal vein in hepatolithiasis: A case report and literature review[J]. Journal of Clinical Hepatology, 2020, 36(9): 2072-2074. doi: 10.3969/j.issn.1001-5256.2020.09.035 |
| [4] | Xu Hui, Zhang Feng, Zhang Ming, Zhu GeYuZheng. Effect of propranolol on hemodynamics and its clinical significance in patients with portal hypertension[J]. Journal of Clinical Hepatology, 2019, 35(4): 801-807. doi: 10.3969/j.issn.1001-5256.2019.04.019 |
| [5] | Xiao Peng, Zhang YaNan, Ba TaoTao, Ding MengMeng, Gao YanHang. Application of serological markers in noninvasive assessment of cirrhotic portal hypertension[J]. Journal of Clinical Hepatology, 2019, 35(9): 2075-2078. doi: 10.3969/j.issn.1001-5256.2019.09.042 |
| [6] | Ma Min, Zhou ZhongYin. Current status of clinical research on hematobilia[J]. Journal of Clinical Hepatology, 2019, 35(2): 438-440. doi: 10.3969/j.issn.1001-5256.2019.02.044 |
| [7] | Mou SiYu, Yang Zhe, Wu LiQun, Qiu Xuan, Guo JiaMing. Predictive factors for portal vein thrombosis after splenectomy in cirrhotic patients with portal hypertension[J]. Journal of Clinical Hepatology, 2018, 34(1): 106-111. doi: 10.3969/j.issn.1001-5256.2018.01.022 |
| [8] | Han Dan, Qi XingShun, Yu Yang, Zhu Qiang, Guo XiaoZhong. An excerpt of portal hypertensive bleeding in cirrhosis: risk stratification, diagnosis and management - 2016 practice guidance by the American Association for the Study of Liver Diseases[J]. Journal of Clinical Hepatology, 2017, 33(3): 422-427. doi: 10.3969/j.issn.1001-5256.2017.03.004 |
| [9] | Nie Wei, Lin Wei, Liang Shan, Fan ZuoPeng, Chou LiXia, Liu YiRong, Ma LiXia, Wei XinHuan, Hu ZhongJie, Zhang Jing. Clinical features of cirrhotic patients with different degrees of portal vein thrombosis and their clinical significance[J]. Journal of Clinical Hepatology, 2017, 33(3): 472-475. doi: 10.3969/j.issn.1001-5256.2017.03.015 |
| [10] | Wang QunRu, Zhang Yong, Mou Dong, Chen BeiJin, Ni Hua, Gao Hui. Association between hematobilia and primary disease after therapeutic endoscopic retrograde cholangiopancreatography[J]. Journal of Clinical Hepatology, 2017, 33(5): 896-898. doi: 10.3969/j.issn.1001-5256.2017.05.021 |
| [11] | Zhai YaNan, Li Lei, Yin Liang, Guo QiHong, Lei JunQiang, Guo ShunLin, Zhang ChunYu, Wang HaiJun, Wen XiaoXiao. Role of dual-source CT low-dose whole liver perfusion imaging in evaluating liver blood perfusion after transjugular intrahepatic portosystemic shunt in cirrhotic patients with portal hypertension[J]. Journal of Clinical Hepatology, 2016, 32(10): 1894-1899. doi: 10.3969/j.issn.1001-5256.2016.10.014 |
| [12] | Bao HanKang, Wei XiuLi. Clinical effects of hand-assisted laparoscopic vs open splenectomy combined with pericardial devascularization the treatment of portal hypertension in liver cirrhosis[J]. Journal of Clinical Hepatology, 2015, 31(3): 431-433. doi: 10.3969/j.issn.1001-5256.2015.03.027 |
| [13] | Lu XiaoMin, Wang ZhenNing, Yang Jun. Significance of molecular markers of prethrombotic state in monitoring portal vein thrombosis in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2015, 31(3): 404-406. doi: 10.3969/j.issn.1001-5256.2015.03.022 |
| [14] | Tang CaiXi, Zhao ZhiJian, Feng Bin, Yang KaiQing. Surgical treatment of cholangiolithiasis with cavernous transformation of the portal vein: a review and analysis of 18 cases[J]. Journal of Clinical Hepatology, 2014, 30(1): 39-41. doi: 10.3969/j.issn.1001-5256.2014.01.013 |
| [15] | Liu ChaoHui, Chen YiJie, Zhang ChengHua. Effects of splenectomy on peripheral blood Th17 cells and immune function in patients with portal hypertension[J]. Journal of Clinical Hepatology, 2014, 30(9): 887-890. doi: 10.3969/j.issn.1001-5256.2014.09.012 |
| [16] | Duan LiWei, Sun Han, Chen YongSheng, Tian YueLi, Li DongFu. Hemodynamic effects of partial splenic artery embolization in patients with liver cirrhosis and portal hypertension[J]. Journal of Clinical Hepatology, 2013, 29(2): 142-145. |
| [17] | Shang JianZhong, Ma LongFei, Ma HongWei, Zhao QiuFang, Zhao LinHua, Li XiaoFei, Fan YanFeng, Zhang SuE. Effect of autologous bone marrow- derived mesenchymal stem cells on portal hemodynamics in patients with liver cirrhosis[J]. Journal of Clinical Hepatology, 2013, 29(11): 848-851. doi: 10.3969/j.issn.1001-5256.2013.10.012 |
| [18] | Wang JiHeng, Gao Ge, Shi JiuJian. Causes and countermeasures of delayed hemobilia after endoscopic retrograde cholangiopancreatography[J]. Journal of Clinical Hepatology, 2013, 29(9): 692-694. doi: 10.3969/j.issn.1001-5256.2013.09.015 |
| [19] | Zhang WenHua, Jia WenLing, Zhou ZiYing, Tang HaiTao, Wang FengMei. Investigation on the method and safety of the non-heparinized plasma exchange therapy in treating patients with hepatic failure[J]. Journal of Clinical Hepatology, 2012, 28(1): 50-52. |
DownLoad: